Completed PHASE4 INTERVENTIONAL NCT00257790

The Tobramycin Study

Tobramycin én Gang Daglig Mot Tre Ganger Daglig, Gitt Med Benzylpenicillin, Til Pasienter Med nøytropen Feber

Sponsor: Oslo University Hospital

Updated 5 times since 2017 Last updated: Jul 3, 2011 Started: Sep 30, 2001 Completion: Mar 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cancer and Fever and is currently completed. Oslo University Hospital leads this study, which shows 5 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital
Sentralsjukehuset i Hedemark
Sentralsjukehuset i Rogaland
Sorlandet Hospital HF
Sykehuset Asker og Baerum
Sykehuset Buskerud
Sykehuset Innlandet HF
The Hospital of Vestfold
The National Institute of Health, Oslo
Ullevaal University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.